Novel information on the epitope of an inverse agonist monoclonal antibody provides insight into the structure of the TSH receptor

PLoS ONE

Volumn 7, Issue 2, 2012, Pages

  Chen, Chun Rong ^a,b   Salazar, Larry M ^a   McLachlan, Sandra M ^a,b   Rapoport, Basil ^a,b  

^a CEDARS SINAI MEDICAL CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE; EPITOPE; LEUCINE; MONOCLONAL ANTIBODY; THYROTROPIN RECEPTOR; DIAGNOSTIC AGENT;

AMINO ACID SUBSTITUTION; ANTIGEN BINDING; ARTICLE; BINDING AFFINITY; CARBOXY TERMINAL SEQUENCE; CHO CELL; CONTROLLED STUDY; CRYSTAL STRUCTURE; GENE MUTATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEIN STRUCTURE; SIGNAL TRANSDUCTION; STRUCTURE ANALYSIS; CHEMISTRY; GENETICS; HUMAN; IMMUNOLOGY; PROTEIN CONFORMATION;

AMINO ACID SUBSTITUTION; ANTIBODIES, MONOCLONAL; EPITOPES; HUMANS; PROTEIN CONFORMATION; RECEPTORS, THYROTROPIN;

EID: 84863165339     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0031973     Document Type: Article

References (33)

1. Palczewski K, Kumasaka T, Hori T, Behnke CA, Motoshima H, et al. (2000) Crystal structure of rhodopsin: A G protein-coupled receptor. Science 289: 739-745.
2. Rasmussen SG, Choi HJ, Rosenbaum DM, Kobilka TS, Thian FS, et al. (2007) Crystal structure of the human beta2 adrenergic G-protein-coupled receptor. Nature 450: 383-387.
3. Cherezov V, Rosenbaum DM, Hanson MA, Rasmussen SG, Thian FS, et al. (2007) High-resolution crystal structure of an engineered human beta2-adrenergic G protein-coupled receptor. Science 318: 1258-1265.
4. Jaakola VP, Griffith MT, Hanson MA, Cherezov V, Chien EY, et al. (2008) The 2.6 angstrom crystal structure of a human A2A adenosine receptor bound to an antagonist. Science 322: 1211-1217.
5. Fan QR, Hendrickson WA, (2005) Structure of human follicle-stimulating hormone in complex with its receptor. Nature 433: 269-277.
6. Sanders J, Chirgadze DY, Sanders P, Baker S, Sullivan A, et al. (2007) Crystal Structure of the TSH Receptor in Complex with a Thyroid-Stimulating Autoantibody. Thyroid 17: 395-410.
7. Nagayama Y, Wadsworth HL, Chazenbalk GD, Russo D, Seto P, et al. (1991) Thyrotropin-luteinizing hormone/chorionic gonadotropin receptor extracellular domain chimeras as probes for TSH receptor function. Proc Natl Acad Sci USA 88: 902-905.
8. Kosugi S, Ban T, Akamizu T, Kohn LD, (1991) Further characterization of a high affinity thyrotropin binding site on the rat thyrotropin receptor which is an epitope for blocking antibodies from idiopathic myxedema patients but not thyroid stimulating antibodies from Graves' patients. Biochem Biophys Res Comm 180: 1118-1124.
9. Costagliola S, Panneels V, Bonomi M, Koch J, Many MC, et al. (2002) Tyrosine sulfation is required for agonist recognition by glycoprotein hormone receptors. EMBO J 21: 504-513.
10. Mueller S, Kleinau G, Jaeschke H, Paschke R, Krause G, (2008) Extended hormone binding site of the human thyroid stimulating hormone receptor: distinctive acidic residues in the hinge region are involved in bovine thyroid stimulating hormone binding and receptor activation. J Biol Chem 283: 18048-18055.
11. Moyle WR, Lin W, Myers RV, Cao D, Kerrigan JE, et al. (2005) Models of glycoprotein hormone receptor interaction. Endocrine 26: 189-205.
12. Nunez MR, Sanders J, Jeffreys J, Depraetere H, Evans M, et al. (2004) Analysis of the thyrotropin receptor-thyrotropin interaction by comparative modeling. Thyroid 14: 991-1011.
13. Kleinau G, Krause G, (2009) Thyrotropin and homologous glycoprotein hormone receptors: structural and functional aspects of extracellular signaling mechanisms. Endocr Rev 30: 133-151.
14. Chen CR, McLachlan SM, Rapoport B, (2009) A monoclonal antibody with thyrotropin (TSH) receptor inverse agonist and TSH antagonist activities binds to the receptor hinge region as well as to the leucine-rich domain. Endocrinol 150: 3401-3408.
15. Chen C-R, McLachlan SM, Rapoport B, (2010) TSH receptor residue E251 in the extracellular leucine-ric repeat domain is critical for linking TSH binding to receptor activation. Endocrinol 151: 1940-1947.
16. Chen CR, McLachlan SM, Rapoport B, (2007) Suppression of thyrotropin receptor constitutive activity by a monoclonal antibody with inverse agonist activity. Endocrinol 148: 2375-2382.
17. Smits G, Campillo M, Govaerts C, Janssens V, Richter C, et al. (2003) Glycoprotein hormone receptors: determinants in leucine-rich repeats responsible for ligand specificity. EMBO J 22: 2692-2703.
18. Nunez MR, Sanders J, Chirgadze DY, Blundell TL, Furmaniak J, et al. (2008) FSH and TSH binding to their respective receptors: similarities, differences and implication for glycoprotein hormone specificity. J Mol Endocrinol 41: 145-164.
19. Sanders J, Evans M, Premawardhana LD, Depraetere H, Jeffreys J, et al. (2003) Human monoclonal thyroid stimulating autoantibody. Lancet 362: 126-128.
20. Chazenbalk GD, Kakinuma A, Jaume JC, McLachlan SM, Rapoport B, (1996) Evidence for negative cooperativity among human thyrotropin receptors overexpressed in mammalian cells. Endocrinol 137: 4586-4591.
21. Johnstone AP, Cridland JC, Da Costa CR, Nussey SS, Shepherd PS, (2003) A functional site on the human TSH receptor: a potential therapeutic target in Graves' disease. Clin Endocrinol 59: 437-441.
22. Kleinau G, Mueller S, Jaeschke H, Grzesik P, Neumann S, et al. (2011) Defining structural and functional dimensions of the extracellular thyrotropin receptor region. J Biol Chem 286: 22622-22631.
23. Chen CR, McLachlan SM, Rapoport B, (2008) Identification of key amino acid residues in a thyrotropin receptor monoclonal antibody epitope provides insight into its inverse agonist and antagonist properties. Endocrinol 149: 3427-3434.
24. Nunez MR, Sanders J, Chirgadze D, Furmaniak J, Rees SB, (2009) Thyroid stimulating autoantibody M22 mimics TSH binding to the TSH receptor leucine rich domain: a comparative structural study of protein-protein interactions. J Mol Endocrinol 42: 381-395.
25. Chazenbalk GD, Pichurin P, Chen CR, Latrofa F, Johnstone AP, et al. (2002) Thyroid-stimulating autoantibodies in Graves disease preferentially recognize the free A subunit, not the thyrotropin holoreceptor. J Clin Invest 110: 209-217.
26. Mizutori Y, Chen CR, Latrofa F, McLachlan SM, Rapoport B, (2008) Evidence that shed TSH receptor A-subunits drive affinity maturation of autoantibodies causing Graves' disease. J Clin Endocrinol Metab 94: 935.
27. Costagliola S, Khoo D, Vassart G, (1998) Production of bioactive amino-terminal domain of the thyrotropin receptor via insertion in the plasma membrane by a glycosylphosphatidylinositol anchor. FEBS Lett 436: 427-433.
28. Chen CR, McLachlan SM, Rapoport B, (2011) Evidence that the thyroid-stimulating hormone (TSH) receptor transmembrane domain influences kinetics of TSH binding to the receptor ectodomain. J Biol Chem 286: 6219-6224.
29. Chen C-R, Pichurin P, Nagayama Y, Latrofa F, Rapoport B, et al. (2003) The thyrotropin receptor autoantigen in Graves' disease is the culprit as well as the victim. J Clin Invest 111: 1897-1904.
30. Zhang M, Phuong K, Tong T, Fremont V, Chen J, et al. (2000) The extracellular domain suppresses constitutive activity of the transmembrane domain of the human TSH receptor: implications for hormone-receptor interaction and antagonist design. Endocrinol 141: 3514-3517.
31. Vlaeminck-Guillem V, Ho SC, Rodien P, Vassart G, Costagliola S, (2002) Activation of the cAMP pathway by the TSH receptor involves switching of the ectodomain from a tethered inverse agonist to an agonist. Mol Endocrinol 16: 736-746.
32. Nagayama Y, Kaufman KD, Seto P, Rapoport B, (1989) Molecular cloning, sequence and functional expression of the cDNA for the human thyrotropin receptor. Biochem Biophys Res Comm 165: 1184-1190.
33. Mizutori Y, Chen C-R, McLachlan SM, Rapoport B, (2008) The thyrotropin receptor hinge region is not simply a scaffold for the leucine-rich domain but contributes to ligand binding and signal transduction. Molec Endocrinol 22: 1171-1182.